Lion Point Capital, LP
Filing Date
Global Rank
#8,002
/ 8,700
▲ 657
Top Industry
Biotechnology
86.7%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
35 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
8.0%
−0.6 pts
Top 5
32.9%
−0.3 pts
Top 10
55.0%
+0.4 pts
HHI
420
Diversified+4
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $20,905,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | −2,149,926 | 52,928 | $1,670,407 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
35 tracked positions ·
$20,905,000 total
· filing declares
35 positions · $20,905,264
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CUE |
Cue Biopharma, Inc.
Healthcare
|
Reduced | 52,928 | $1,670,407 | 7.99% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 4,450 | $1,489,815 | 7.13% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 67,500 | $1,314,225 | 6.29% | |
| FENC |
Fennec Pharmaceuticals Inc.
Healthcare
|
Held | 112,434 | $1,208,665 | 5.78% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Held | 21,400 | $1,199,898 | 5.74% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Held | 80,000 | $1,132,000 | 5.41% | |
| MIST |
Milestone Pharmaceuticals Inc.
Healthcare
|
Held | 820,000 | $1,098,800 | 5.26% | |
| BNTC |
Benitec Biopharma Inc.
Healthcare
|
Held | 62,000 | $829,560 | 3.97% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Held | 36,000 | $786,960 | 3.76% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 51,700 | $769,296 | 3.68% | |
| GERN |
Geron Corp
Healthcare
|
Held | 578,000 | $739,840 | 3.54% | |
| QURE |
uniQure N.V.
Healthcare
|
Held | 14,700 | $677,082 | 3.24% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Held | 128,650 | $656,115 | 3.14% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
Held | 5,500 | $610,170 | 2.92% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 8,100 | $592,434 | 2.83% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Held | 28,500 | $512,145 | 2.45% | |
| HUMA |
Humacyte, Inc.
Healthcare
|
Held | 650,000 | $507,000 | 2.43% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Held | 46,000 | $504,620 | 2.41% | |
| VTRS |
Viatris Inc
Healthcare
|
Held | 27,700 | $439,876 | 2.10% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Held | 18,000 | $399,780 | 1.91% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Held | 5,000 | $372,400 | 1.78% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 9,100 | $369,733 | 1.77% | |
| PCRX |
Pacira BioSciences, Inc.
Healthcare
|
Held | 13,500 | $342,495 | 1.64% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Held | 26,600 | $318,668 | 1.52% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 86,000 | $294,120 | 1.41% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Held | 19,000 | $291,840 | 1.40% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 10,500 | $283,290 | 1.36% | |
| GHRS |
GH Research PLC
Healthcare
|
Held | 10,200 | $274,176 | 1.31% | |
| MCRB |
Seres Therapeutics, Inc.
Healthcare
|
Held | 31,570 | $249,087 | 1.19% | |
| AZTA |
Azenta, Inc.
Healthcare
|
Held | 9,700 | $247,544 | 1.18% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Held | 465,000 | $195,765 | 0.94% | |
| INVA |
Innoviva, Inc.
Healthcare
|
Held | 8,200 | $186,222 | 0.89% | |
| IPHA |
Innate Pharma SA
Healthcare
|
Held | 81,151 | $149,317 | 0.71% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Held | 5,250 | $137,655 | 0.66% | |
| SPRB |
Spruce Biosciences, Inc.
Healthcare
|
Held | 1,000 | $54,000 | 0.26% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.